ODDB.org: Open Drug Database

Mepha Pharma AG - Buprenorphin-Mepha 35ug/h, Transdermale Pflaster

Swissmedic Registration	65809	Sequence	01
Product name	Buprenorphin-Mepha 35ug/h	Description	Transdermale Pflaster
ATC-Classification	N02AE01	ATC-Description	Buprenorphine
Introduction of Sequence	19.05.2015

Composition

buprenorphinum 20 mg, oleylis oleas, povidonum K 90, acidum laevulinicum, acrylates et vinylis acetatis polymerisatum (vernetzt), poly(ethylenis terephthalas), acrylates et vinylis acetatis polymerisatum (nicht vernetzt), Trägermaterial: poly(ethylenis terephthalas), ad praeparationem pro 25 cm², cum liberatione 35 µg/h.

Packungsbestandteile

Galenic Form

Transdermale Pflaster

Excipiens

Active Agent	Dose
Buprenorphine	20 mg

BAG: Active Agent	Dose
Buprenorphine	20 mg

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
007	4	28.12	47.00	A+	SL	Yes
008	8	53.66	74.75	A+	SL	Yes

2025	©ywesee GmbH